- Home
- NYCB vs IOVA Comparison
NYCB vs IOVA Comparison
Compare NYCB & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYCB
- IOVA
- Stock Information
- Founded
- NYCB 1859
- IOVA 2007
- Country
- NYCB United States
- IOVA United States
- Employees
- NYCB N/A
- IOVA N/A
- Industry
- NYCB Banks
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NYCB Finance
- IOVA Health Care
- Exchange
- NYCB Nasdaq
- IOVA Nasdaq
- Market Cap
- NYCB 3.9B
- IOVA 3.6B
- IPO Year
- NYCB 1993
- IOVA N/A
- Fundamental
- Price
- NYCB $10.82
- IOVA $10.07
- Analyst Decision
- NYCB Hold
- IOVA Strong Buy
- Analyst Count
- NYCB 15
- IOVA 10
- Target Price
- NYCB $13.58
- IOVA $24.80
- AVG Volume (30 Days)
- NYCB 5.5M
- IOVA 6.2M
- Earning Date
- NYCB 10-24-2024
- IOVA 11-05-2024
- Dividend Yield
- NYCB 6.60%
- IOVA N/A
- EPS Growth
- NYCB N/A
- IOVA N/A
- EPS
- NYCB N/A
- IOVA N/A
- Revenue
- NYCB $2,026,000,000.00
- IOVA $32,772,000.00
- Revenue This Year
- NYCB N/A
- IOVA $13,836.92
- Revenue Next Year
- NYCB N/A
- IOVA $183.20
- P/E Ratio
- NYCB N/A
- IOVA N/A
- Revenue Growth
- NYCB N/A
- IOVA 13669.75
- 52 Week Low
- NYCB $5.10
- IOVA $3.21
- 52 Week High
- NYCB $35.37
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- NYCB 50.14
- IOVA 44.01
- Support Level
- NYCB $9.51
- IOVA $8.80
- Resistance Level
- NYCB $11.14
- IOVA $11.80
- Average True Range (ATR)
- NYCB 0.48
- IOVA 0.61
- MACD
- NYCB -0.06
- IOVA -0.29
- Stochastic Oscillator
- NYCB 49.22
- IOVA 24.39
About NYCB New York Community Bancorp Inc.
New York Community Bancorp Inc is the bank holding company. It is a New York State-chartered savings bank that operates through eight local divisions: Queens County Savings Bank, Roslyn Savings Bank, Richmond County Savings Bank, Roosevelt Savings Bank, and Atlantic Bank in New York; Garden State Community Bank in New Jersey; Ohio Savings Bank in Ohio, and AmTrust Bank in Florida and Arizona. The bank competes for depositors in diverse markets with a comprehensive menu of products and services, and access to multiple service channels, including online banking, mobile banking, and banking by phone. It is also a producer of multi-family loans in New York City.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.